期刊文献+

妇女“两癌”筛查管理流程优化与实践研究 被引量:2

Research on the optimization and practice of management process of National Cervical and Breast Screening Program for Women
原文传递
导出
摘要 目的对济南市槐荫区妇女“两癌”筛查工作存在的问题进行梳理分析,建立“两癌”筛查管理新流程,以期促进筛查管理制度化、规范化,提高妇女参加筛查的积极性和满意度,为其他区县该项工作的开展提供参考。方法通过问卷调查,了解妇女对管理流程优化项目的满意度,制定并实践该优化方案。结果优化筛查管理流程后,济南市槐荫区妇女对检查环境、等候时间、服务态度、流程安排等满意度均>99%。其中,妇女对等候时间(χ^(2)=173.38)、流程安排(χ^(2)=207.78)的满意度较优化前有所提高,差异有统计学意义(P<0.01),其他指标也较优化前有所改善,且优化后异常/可疑病例随访率达到100%,流程优化明显提升了筛查效果。结论通过对“两癌”筛查管理流程进行优化,打破了以往以“职能”为中心的模式,建立了“两癌”筛查管理新流程,不仅提高了妇女参加筛查的积极性和满意度,也为其他同类公共卫生项目流程管理提供了参考。 Objective To sort out and analyze the problems existing in National Cervical and Breast Screening Program for women in Huaiyin District,Jinan City,and establish a new process of National Cervical and Breast Screening Program for Women management,so as to promote the institutionalization and standardization of screening management,improve the enthusiasm and satisfaction of women to participate in screening,and provide references for the development of this work in other districts and counties.Methods Through the questionnaire survey,knowing the satisfaction of the women to the management process optimization project,formulating and practicing the optimization plan.Results After optimizing the screening management process,more than 99%women in Huaiyin District,Jinan City were satisfied with the inspection environment,waiting time,service attitude and process arrangement.The satisfaction with waiting time(χ^(2)=173.38)and process arrangement(χ^(2)=207.78)improved significantly(P<0.01),other indicators improved compared with those before optimization,and the follow-up rate of abnormal/suspicious cases reached 100%after optimization.It can be seen that the process optimization significantly improved the screening effect.Conclusion By optimizing the process of National Cervical and Breast Screening Program for Women,the previous“function”centered model is broken,and a new process of National Cervical and Breast Screening Program for women is established,which not only improves the enthusiasm and satisfaction of the women to participate in the screening,but also provides references for the process management of other similar public health projects.
作者 张敬 李晨 孙丹丹 王月婷 刘方方 李瑞静 耿玲 ZHANG Jing;LI Chen;SUN Dan-dan;WANG Yue-ting;LIU Fang-fang;LI Rui-jing;GENG Ling(Hospital for Reproductive Medicine Affiliated to Shandong University,Jinan,Shandong 250021,China)
出处 《中国公共卫生管理》 2022年第2期183-186,190,共5页 Chinese Journal of Public Health Management
基金 山东省医药卫生科技发展计划项目(2018WS342)。
关键词 “两癌”筛查 问卷调查 流程优化 济南 National Cervical and Breast Screening Program for Women questionnaire survey process optimization Jinan
  • 相关文献

参考文献5

二级参考文献78

  • 1黎玉兰.健康教育对农村妇女两癌筛查意愿中的临床干预效果[J].医学信息,2018,31(A02):283-284. 被引量:3
  • 2武秋林,曾晓琴,李萍,曾芳玲.妇女病普查疾病谱变化规律的探讨[J].中国妇幼保健,2004,19(12):56-57. 被引量:29
  • 3TOMAO F, PAPA A, ROSSI L, et al. Angiogenesis and antian- giogenic agents in cervical cancer [ J/OL]. Onco Targets Ther, 2014, 7:2237-2248 [ 2015-10-20 ]. http://www, dovepress. com/angiogenesis-and-antiangiogenic -agents-in-cervical-cancer- peer-reviewed-artiele-OTT. DOI:10.2147/OTT. S68286. 被引量:1
  • 4SECORD A A, BLESSING J A, ARMSTRONG D K, et al. Phase Ⅱ trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growthfactor receptor expression: a gynecologic oncology group study [J]. Gynecol On- col, 2008, 108(3) : 493-499. DOI:10. 1016/j. ygyno. 2007.11. 029. 被引量:1
  • 5TEWARI K S, SILL M W, LONG H J, et al. Improved survival with bevacizumab in advanced cervical cancer [ J ]. N Engl J Med, 2014, 370 ( 8 ) : 734-743. DOI: i0. 1056/NEJ- Moa1309748. 被引量:1
  • 6SUH D H, LEE K, KIM K, et al. Major clinical research advanees in gynecologic cancer in 2014 [J]. J Gyneeol Oneol, 2015, 26(2) : 156-167. DOI:10. 3802/jgo. 2015.26.2. 156. 被引量:1
  • 7SHI Y, TUOKAN T, LIN C, et al. Aquaporin 8 involvement in human cervical cancer SiHaMigration via the EGFR-Erkl/2 path- way [J/OL]. Asian Pac J Cancer Prey, 2014, 15(15): 6391- 6395 [ 2015-10-20 ]. http://koreascience, or. kr/article/Arti- cleFullRecord, jsp?cn = POCPA9_2014_vl 5 n15_6391. DOI: 10. 7314/APJCP. 2014.15.15. 6391. 被引量:1
  • 8LIU J, LIANG Y, LIU T, et al. Anti-EGFR-conjugated hollow gold nanospheres enhance radio-cytotoxic targeting of cervical cancer at megavoltage radiation energies [ J/OL]. Nanoscale Res Lett, 2015, 10:218 [ 2015-10-20 ]. http://nanoscalereslett. springeropen, com/articles/10. 1186/s11671-015-0923-2. DOI: 10.1186/sll 671-015-0923-2. 被引量:1
  • 9BUMRUNGTHAI S, MUNJAL K, NANDEKAR S, et al. Epider- mal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications [ J/ OL]. J Transl Med, 2015, 13:244 [2015-10-201. http://transla- tional-medicine, biomedcentral, corn/articles/10. 1186/s12967-015- 0611-0. DOI:10.1186/s129674315-0611-0. 被引量:1
  • 10AGHAJANIAN C, BLANK S V, GOFF B A, et al. OCEANS: a randomized, double-blind, placebo-controlled phase Ⅲ trial of chemotherapy with or without bevacizumab in patients with plati- num-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer[ J]. J Clin Oncol, 2012, 30 (17) : 2039- 2045. DOI : 10. 1200/JCO. 2012.42. 0505. 被引量:1

共引文献45

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部